Performance

PBLS -3.89%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
PBLS	+6.45%	-3.89%*	-3.89%*	—	-45.48%*	0.20*	0.00%*

Summary

PBLS at a glance

PBLS returned -3.89% since Jun 10, 2026. Its worst drop since then was -45.48%, smaller than 29% of stocks on Redstone, and its Sharpe ratio of 0.20 beats 36% of stocks on Redstone. It hasn't paid a dividend since it listed.

Ranking

How PBLS ranks

Dividend Yield Rank *

Current Drawdown

-27.22%

Rolling Volatility

94.77%

Actions

Metrics

Risk Indicators*

Alpha8.47%

Beta0.91x

Sharpe0.20

Sortino0.28

Omega1.03

Calmar-0.09

Martin0.78

Profile

About PBLS

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $3.8B
Listed: Jun 2026
Headquarters: Cambridge, MA
Website: parabilismed.com

Comparisons

PBLS: Parabilis Medicines, Inc.

PBLS at a glance

How PBLS ranks

Current Drawdown

Rolling Volatility

About PBLS

Related comparisons